In the second phase of our study, we investigated the effects of inhibition of microglial reactivity using the colony-stimulating factor-1 receptor (CSF1R) inhibitor (PLX5622) on αSyn accumulation and neurodegeneration in a mouse model of PD induced by PFF injection (Fig. 4a). This evidence concerns the gene CSF1R and Parkinson disease.